Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Steinbusch

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Epilepsia|June 29, 2012
Stress sensitivity of childhood epilepsy is related to experienced negative life eventsJolien S van Campen, Floor E Jansen, Laurie C Steinbusch, et al.
Lung Cancer (Amsterdam, Netherlands)|December 5, 2020
Risk of second primary malignancies among patients with carcinoid of the lungWieneke A Buikhuisen, Laurie C Steinbusch, Liudmila L Kodach, et al.
Clinical Genetics|November 22, 2012
Aging in Rett syndrome: a longitudinal studyN S J Halbach, E E J Smeets, C Steinbusch, et al.
Lung Cancer (Amsterdam, Netherlands)|November 18, 2024
Combined analysis of circulating tumor DNA and tumor tissue to overcome osimertinib resistance (OSIRIS); the second line osimertinib cohortJ W T van der Wel, M Jebbink, D van den Broek, et al.
Nature Communications|May 28, 2025
TEIPP-vaccination in checkpoint-resistant non-small cell lung cancer: a first-in-human phase I/II dose-escalation studyMitchell Emmers, Marij J P Welters, Michelle V Dietz, et al.
Lung Cancer (Amsterdam, Netherlands)|October 3, 2025
Determining the optimal approach to identify osimertinib resistance; the first line osimertinib cohort of the OSIRIS studyJ W T van der Wel, S M Ernst, M Jebbink, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Epilepsia|June 29, 2012
Stress sensitivity of childhood epilepsy is related to experienced negative life eventsJolien S van Campen, Floor E Jansen, Laurie C Steinbusch, et al.
Lung Cancer (Amsterdam, Netherlands)|December 5, 2020
Risk of second primary malignancies among patients with carcinoid of the lungWieneke A Buikhuisen, Laurie C Steinbusch, Liudmila L Kodach, et al.
Clinical Genetics|November 22, 2012
Aging in Rett syndrome: a longitudinal studyN S J Halbach, E E J Smeets, C Steinbusch, et al.
Lung Cancer (Amsterdam, Netherlands)|November 18, 2024
Combined analysis of circulating tumor DNA and tumor tissue to overcome osimertinib resistance (OSIRIS); the second line osimertinib cohortJ W T van der Wel, M Jebbink, D van den Broek, et al.
Nature Communications|May 28, 2025
TEIPP-vaccination in checkpoint-resistant non-small cell lung cancer: a first-in-human phase I/II dose-escalation studyMitchell Emmers, Marij J P Welters, Michelle V Dietz, et al.
Lung Cancer (Amsterdam, Netherlands)|October 3, 2025
Determining the optimal approach to identify osimertinib resistance; the first line osimertinib cohort of the OSIRIS studyJ W T van der Wel, S M Ernst, M Jebbink, et al.
Pageof 1